UK Companies House feature
CMR SURGICAL LIMITED
Profile
- Company number
- 08863657
- Status
- Active
- Incorporation
- 2014-01-27
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- IFRS
- Reporting scope
- Consolidated (group)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. ... The directors have therefore prepared a reasonable downside case, which shows that the Group still has sufficient liquid resources available to meet its liabilities as and when they fall due during the period.”
Subsidiaries
- CMR Surgical Inc · 100% held · USA · Sale and distribution of Versius®
- CMR Surgical Srl · 100% held · Italy · Sale and distribution of Versius®
- CMR Surgical Spain SL · 100% held · Spain · Sale and distribution of Versius®
- CMR Surgical GmbH · 100% held · Germany · Sale and distribution of Versius®
- CMR Surgical SAS · 100% held · France · Sale and distribution of Versius®
- CMR Surgical India Private Ltd · 100% held · India · Sale and distribution of Versius®
- CMR Surgical FZCO · 100% held · UAE · Sale and distribution of Versius®
- CMR Surgical Chile SpA · 100% held · Chile · Sale and distribution of Versius®
- CMR Surgical Device Co Ltd · 77% held · China · Sale and distribution of Versius®
- CMR Surgical Brasil Importacio e Comercio de Equipamentos Medicos Ltda · 100% held · Brazil · Sale and distribution of Versius®
- CMR Surgical AB · 100% held · Sweden · Sale and distribution of Versius®
- Cambridge Medical Robotics Limited · 100% held · England and Wales · dormant
Significant events
- “In October 2024, the Group secured a significant regulatory approval, receiving US FDA De Novo Authorisation for the use of Versius® in cholecystectomy procedures in adults.”
- “The Group obtained CE Mark Approval for the Ultrasonic Dissector, a new addition to the Versius Plus portfolio designed to enhance surgical precision and efficiency by delivering ultrasonic energy for precise cutting and coagulation of tissue.”
- “The Group closed a new fundraising round of £163.5m to support the Group's continued growth and commercial development. Including the receipt of £107m, as of 25 March 2025, the Group had cash reserves of £124m.”
- “The Company obtained further funding from convertible loan notes in Q1 2025 totalling £108.5m.”
- “The Company also obtained a debt facility in Q1 2025 for a further £55m.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
9 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2023-07-12 | — | — |
| BOSE, Supratim | Director | 2023-06-15 | Aug 1952 | Singaporean |
| CASSIDY, John | Director | 2022-10-27 | Jul 1988 | British |
| COLELLA, Massimiliano | Director | 2025-01-02 | Jul 1968 | Italian |
| HURSEVER, Sakip-Umur, Mr. | Director | 2018-05-10 | Apr 1975 | German,Turkish |
| MOORE, Daniel Jeffrey | Director | 2024-07-15 | Mar 1961 | American |
| MOUKHEIBIR, Catherine | Director | 2021-01-01 | Nov 1959 | Lebanese |
| MTIBELISHVILI, Irackli | Director | 2022-10-11 | Oct 1971 | Georgian |
| PLACHTYNA, Steven | Director | 2024-11-05 | Jul 1990 | American |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAY, Simon Christopher | Secretary | 2017-02-07 | 2023-07-21 |
| CHRISTOU, Victor, Dr | Director | 2018-10-03 | 2019-04-23 |
| FARHAT, Camille | Director | 2019-04-26 | 2021-02-23 |
| FROST, Martin John | Director | 2014-01-27 | 2020-12-31 |
| INDAHL, Reynir | Director | 2015-10-22 | 2018-05-10 |
| KULKOV, Egor | Director | 2016-07-15 | 2022-10-11 |
| LANGAKER, Erik | Director | 2016-07-15 | 2019-12-31 |
| LONDY, Kelly | Director | 2019-01-29 | 2024-02-29 |
| MARSHALL, Keith | Director | 2020-01-01 | 2020-06-30 |
| MCCOMB, William | Director | 2020-09-18 | 2023-03-30 |
| METHI, Per Christian | Director | 2014-01-28 | 2024-05-01 |
| MUZZI, Massimo | Director | 2016-07-15 | 2018-04-23 |
| NERSETH, Per Vegard | Director | 2020-01-01 | 2023-03-27 |
| OIE, Ingeborg Dybdal | Director | 2019-03-26 | 2021-06-28 |
| RANDLE, Steven James | Director | 2014-02-01 | 2015-07-31 |
| SLACK, Mark | Director | 2020-06-30 | 2021-06-28 |
| SLACK, Mark | Director | 2014-02-01 | 2018-04-23 |
| TANSLEY, Robert Giles, Dr | Director | 2019-04-23 | 2019-09-11 |
| TANSLEY, Robert Giles, Dr | Director | 2016-07-15 | 2018-10-03 |
| VERNON, Anthony | Director | 2020-09-01 | 2023-03-29 |
| WELLS, Elizabeth Alice | Director | 2021-08-19 | 2022-10-27 |
| YU, Fan, Mr. | Director | 2023-08-15 | 2024-11-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Egor Kulkov | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2022-12-20 |
| Escala Capital Investments Cyprus Limited | Corporate entity | ownership-of-shares-50-to-75-percent-as-firm, voting-rights-50-to-75-percent-as-firm, right-to-appoint-and-remove-directors-as-firm | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 190 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-21 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-01-16 | SH01 | capital | capital allotment shares |
| 2025-07-09 | SH01 | capital | capital allotment shares |
| 2025-05-19 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-05-02 | SH01 | capital | capital allotment shares |
| 2025-04-14 | AA | accounts | accounts with accounts type group |
| 2025-04-03 | RESOLUTIONS | resolution | resolution |
| 2025-04-03 | SH01 | capital | capital allotment shares |
| 2025-04-01 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-03-28 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-03-28 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-03-28 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-03-26 | SH01 | capital | capital allotment shares |
| 2025-03-04 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-03-03 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-02-27 | AP01 | officers | appoint person director company with name date |
| 2025-02-18 | RESOLUTIONS | resolution | resolution |
| 2025-02-18 | MA | incorporation | memorandum articles |
| 2025-01-29 | AP01 | officers | appoint person director company with name date |
| 2025-01-17 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.